Sections
Title | Starting Page | Number of Pages |
---|
1 Table of Contents | 2 | 4 |
1.1 List of Tables | 4 | 1 |
1.2 List of Figures | 5 | 1 |
2 Introduction | 6 | 1 |
2.1 Cranio Maxillofacial Fixation (CMF) Overview | 6 | 1 |
3 Products under Development | 7 | 5 |
3.1 Cranio Maxillofacial Fixation (CMF) - Pipeline Products by Stage of Development | 7 | 1 |
3.2 Cranio Maxillofacial Fixation (CMF) - Pipeline Products by Segment | 8 | 1 |
3.3 Cranio Maxillofacial Fixation (CMF) - Pipeline Products by Territory | 9 | 1 |
3.4 Cranio Maxillofacial Fixation (CMF) - Pipeline Products by Regulatory Path | 10 | 1 |
3.5 Cranio Maxillofacial Fixation (CMF) - Pipeline Products by Estimated Approval Date | 11 | 1 |
4 Cranio Maxillofacial Fixation (CMF) - Pipeline Products under Development by Companies | 12 | 2 |
4.1 Cranio Maxillofacial Fixation (CMF) Companies - Pipeline Products by Stage of Development | 12 | 1 |
4.2 Cranio Maxillofacial Fixation (CMF) - Pipeline Products by Stage of Development | 13 | 1 |
5 Cranio Maxillofacial Fixation (CMF) Companies and Product Overview | 14 | 13 |
5.1 Advanced BioMedical Technologies, Inc. Company Overview | 14 | 1 |
5.1.1 Advanced BioMedical Technologies, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 14 | 2 |
5.2 Clemson University Company Overview | 16 | 1 |
5.2.1 Clemson University Pipeline Products &Ongoing Clinical Trials Overview | 16 | 1 |
5.3 Histocell S.L. Company Overview | 17 | 1 |
5.3.1 Histocell S.L. Pipeline Products &Ongoing Clinical Trials Overview | 17 | 1 |
5.4 IlluminOss Medical, Inc. Company Overview | 18 | 1 |
5.4.1 IlluminOss Medical, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 18 | 2 |
5.5 OssDsign AB Company Overview | 20 | 1 |
5.5.1 OssDsign AB Pipeline Products &Ongoing Clinical Trials Overview | 20 | 2 |
5.6 OsteoVantage, Inc. Company Overview | 22 | 1 |
5.6.1 OsteoVantage, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 22 | 1 |
5.7 Renishaw Plc Company Overview | 23 | 1 |
5.7.1 Renishaw Plc Pipeline Products &Ongoing Clinical Trials Overview | 23 | 1 |
5.8 University of South Florida Company Overview | 24 | 1 |
5.8.1 University of South Florida Pipeline Products &Ongoing Clinical Trials Overview | 24 | 1 |
5.9 Xtant Medical Holdings, Inc. Company Overview | 25 | 1 |
5.9.1 Xtant Medical Holdings, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 25 | 2 |
6 Cranio Maxillofacial Fixation (CMF)- Recent Developments | 27 | 11 |
6.1 Sep 14, 2016: SpineGuard Reports Six-Month 2016 Financial Results | 27 | 1 |
6.2 Sep 04, 2016: Cranioplasty using OSSDSIGN Cranial - preliminary data from a retrospective study | 28 | 1 |
6.3 Sep 01, 2016: Cantel Medical Promotes Seth M. Yellin to Executive Vice President | 28 | 1 |
6.4 Aug 29, 2016: Xtant Medical Files Registration Statement for Rights Offering of Shares for up to USD15 Million | 28 | 1 |
6.5 Aug 19, 2016: Xtant Medical Receives Non Compliance Notice from NYSE MKT | 28 | 1 |
6.6 Aug 16, 2016: Xtant Medical Expands AR Credit Facility with Silicon Valley Bank | 29 | 1 |
6.7 Aug 01, 2016: Xtant Medical Reports Second Quarter 2016 Results | 29 | 1 |
6.8 Aug 01, 2016: Cantel Medical Names Jorgen B. Hansen as New President and CEO | 30 | 1 |
6.9 Jul 28, 2016: Zimmer Biomet Reports Second Quarter 2016 Financial Results | 31 | 1 |
6.10 Jul 26, 2016: Xtant Medical Announces the Operations Expansion of Montana s Tissue Processing Rooms | 31 | 1 |
6.11 Jul 21, 2016: Stryker reports second quarter 2016 results | 32 | 1 |
6.12 Jul 20, 2016: Xtant Medical Pre-Announces Second Quarter 2016 Revenue and EBITDA | 33 | 1 |
6.13 Jul 19, 2016: Materialise Enters into Distribution Agreement with DePuy Synthes | 33 | 1 |
6.14 Jul 12, 2016: SpineGuard Reports 29% Growth and 1.9M Revenue for the Second Quarter 2016 | 34 | 1 |
6.15 Jun 17, 2016: Cantel Medical Announces Appointment of Dr. Ronnie Myers to its Board of Directors | 34 | 1 |
6.16 Jun 16, 2016: Xtant Medical Announces Changes to Its Executive Management and Board of Directors | 34 | 1 |
6.17 Jun 13, 2016: Zimmer Biomet Raises USD1.28 Billion in Public Offering of Shares | 35 | 1 |
6.18 Jun 08, 2016: Cantel Medical Announces Record Financial Results for Third Quarter 2016 | 36 | 1 |
6.19 Jun 07, 2016: Zimmer Biomet Plans to Raise USD750 Million in Public Offering of Notes | 37 | 1 |
6.20 May 26, 2016: Xtant Medical completes new accounts receivable revolver credit facility with Silicon Valley Bank | 37 | 1 |
6.21 May 02, 2016: Xtant Medical Raises USD65 Million in Private Placement of Notes | 37 | 1 |
7 Appendix | 38 | 4 |
7.1 Methodology | 38 | 2 |
7.2 About GlobalData | 40 | 1 |
7.3 Contact Us | 40 | 1 |
7.4 Disclaimer | 41 | 1 |